|
Mechanism30S subunit inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
100 Deals associated with Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.